| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2011 | WO2011033085A1 Rapidly soluble solid pharmaceutical preparations containing amphiphilic copolymers based on polyethers in combination with hydrophilic polymers |
| 03/24/2011 | WO2011033055A1 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | WO2011033045A1 Heterocyclic antiviral compounds |
| 03/24/2011 | WO2011033018A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines |
| 03/24/2011 | WO2011033010A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases |
| 03/24/2011 | WO2011033009A1 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl] benzamide compounds, their preparation and their use as tace inhibitors |
| 03/24/2011 | WO2011032984A1 Lubiprostone for obstetrical or gynecological applications |
| 03/24/2011 | WO2011032929A1 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability |
| 03/24/2011 | WO2011032907A1 Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants |
| 03/24/2011 | WO2011032903A1 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/24/2011 | WO2011032896A2 Encapsulation using wax-type substances |
| 03/24/2011 | WO2011032882A1 Orally disintegrating pharmaceutical dosage form containing aripiprazole |
| 03/24/2011 | WO2011032697A1 "dietary supplement stimulating the male sexual function" |
| 03/24/2011 | WO2011032563A1 Medical use of spla2 hydrolysable liposomes |
| 03/24/2011 | WO2011032416A1 Pharmaceutical composition containing dopamine receptor agonist |
| 03/24/2011 | WO2011032320A1 Novel alkene oxindole derivatives |
| 03/24/2011 | WO2011032318A1 Stable artesunate-amodiaquine hydrochloride complex tablet and preparation method thereof |
| 03/24/2011 | WO2011032291A1 Selective calcium channel modulators |
| 03/24/2011 | WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors |
| 03/24/2011 | WO2011032229A1 A novel epsilon polymorphic form of inulin and compositions comprising same |
| 03/24/2011 | WO2011032214A1 A method for the n-demethylation of n-methyl heterocycles |
| 03/24/2011 | WO2011032204A1 Treatment of neurological conditions |
| 03/24/2011 | WO2011032203A1 Contact lens disinfecting solutions |
| 03/24/2011 | WO2011032192A1 Substituted clavulanic acid |
| 03/24/2011 | WO2011014793A9 Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |
| 03/24/2011 | WO2011013141A3 Substituted benzamide derivatives as glucokinase (gk) activators |
| 03/24/2011 | WO2011012885A9 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer |
| 03/24/2011 | WO2011012140A3 Polymorphs of rasagiline hydrochloride |
| 03/24/2011 | WO2011009530A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases |
| 03/24/2011 | WO2011009095A8 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide |
| 03/24/2011 | WO2010150102A3 Method for isolating cimiracemate a |
| 03/24/2011 | WO2010149980A3 Topical formulation containing a tetracycline and a method of treating skin infections using the same |
| 03/24/2011 | WO2010149363A3 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis |
| 03/24/2011 | WO2010148007A9 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 03/24/2011 | WO2010140765A3 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same |
| 03/24/2011 | WO2010138670A3 Thiocolchicine derivatives, method of making and methods of use thereof |
| 03/24/2011 | WO2010136000A3 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
| 03/24/2011 | WO2010132684A3 Inhibitors of inv(16) leukemia |
| 03/24/2011 | WO2010132562A3 Transdermal delivery of metformin |
| 03/24/2011 | WO2010131922A3 Amide compound, preparation method thereof and pharmaceutical composition comprising same |
| 03/24/2011 | WO2010131887A3 Composition for preventing hair loss or for stimulating hair growth |
| 03/24/2011 | WO2010131865A3 Antimicrobial composition with an activity against an antibiotic-resistant strain |
| 03/24/2011 | WO2010129406A3 Methods of promoting muscle growth |
| 03/24/2011 | WO2010129053A3 Egfr inhibitors and methods of treating disorders |
| 03/24/2011 | WO2010129048A3 Therapeutic compounds |
| 03/24/2011 | WO2010128793A3 Fat soluble vitamin and a derivative thereof induced by novel cationic chitosan, a method of producing same and drug delivery system containing same |
| 03/24/2011 | WO2010127231A3 Moisturizing antimicrobial composition |
| 03/24/2011 | WO2010127209A3 Compositions and methods for therapy of macular degeneration |
| 03/24/2011 | WO2010127096A3 Novel therapeutic treatments using centhaquin |
| 03/24/2011 | WO2010124201A3 Compositions and methods for treatment of cardiovascular disease |
| 03/24/2011 | WO2010123591A3 Small molecule inhibitors of nads, namnat, and nmnat |
| 03/24/2011 | WO2010123583A3 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof |
| 03/24/2011 | WO2010123221A3 Composition for preventing and improving the symptoms of menopause, containing glyceollins as an active ingredient |
| 03/24/2011 | WO2010120875A3 Treatment of skin damage |
| 03/24/2011 | WO2010120872A3 Method of decreasing pro-adam10 secretase and/or beta secretase levels |
| 03/24/2011 | WO2010119300A3 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |
| 03/24/2011 | WO2010118200A3 Liposomal formulations of tocopheryl amides |
| 03/24/2011 | WO2010117787A3 Inhibiting eph b-3 kinase |
| 03/24/2011 | WO2010111653A3 Modulating ires-mediated translation |
| 03/24/2011 | WO2010108125A3 Psma-targeting compounds and uses thereof |
| 03/24/2011 | WO2010105093A3 Implantable device for long-term delivery of drugs |
| 03/24/2011 | WO2010105021A3 Bioburden-reducing antibiotic composition and method of use |
| 03/24/2011 | WO2010092597A3 Liposomal citicoline injection |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | WO2010091381A3 An intermittent dosing strategy for treating rheumatoid arthrtis |
| 03/24/2011 | WO2010087981A3 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| 03/24/2011 | WO2010084052A3 Use of cationic surfactants as acaricidal agents |
| 03/24/2011 | WO2010039892A8 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | WO2010014134A8 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/24/2011 | WO2009158499A3 Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems |
| 03/24/2011 | WO2009143174A3 Chemical permeation enhancers enhance nerve blockade by toxins |
| 03/24/2011 | US20110072527 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/24/2011 | US20110071226 Emollient composition |
| 03/24/2011 | US20110071225 Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof |
| 03/24/2011 | US20110071224 Novel gamma-secretase inhibitor |
| 03/24/2011 | US20110071223 Body cosmetics for wetted skin |
| 03/24/2011 | US20110071222 Potentiators of insulin secretion |
| 03/24/2011 | US20110071221 Method for treating conditions mediated by ppar using macelignan |
| 03/24/2011 | US20110071219 Hemostatic Effects of Glucono-Delta-Lactone |
| 03/24/2011 | US20110071218 Novel amino acid derivatives, method for preparing same, and therapeutic use thereof |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071216 Reconstitutable reverse thermal gelling polymers |
| 03/24/2011 | US20110071215 Compositions and methods for diagnosis, prognosis and treatment of mesothelioma |
| 03/24/2011 | US20110071214 Methods and compositions for the treatment of cancer |
| 03/24/2011 | US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071209 RNAi Modulation of the RHO-A Gene and Uses Thereof |
| 03/24/2011 | US20110071208 Lipid encapsulated dicer-substrate interfering rna |
| 03/24/2011 | US20110071207 Oligomer-Aryloxy-Substituted Propanamine Conjugates |
| 03/24/2011 | US20110071206 Modulators of ATP-Binding Cassette Transporters |
| 03/24/2011 | US20110071204 Percutaneous absorption preparation |
| 03/24/2011 | US20110071203 Transmucosal veterinary composition comprising detomidine |
| 03/24/2011 | US20110071202 Anti-hepatitis c virus agents and anti-hiv agents |
| 03/24/2011 | US20110071200 3-amino-benzo [d] isothiazole dioxide derivatives and their use as pesticides |
| 03/24/2011 | US20110071199 Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease |
| 03/24/2011 | US20110071198 Nicotinic acid receptor ligands |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |